Cue Biopharma, Inc.CUENASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-37.53M
↓ 14% below average
Average (9y)
$-32.95M
Historical baseline
Range
High:$-1.88M
Low:$-50.49M
CAGR
+39.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-37.53M | +18.5% |
| 2023 | $-46.05M | +8.8% |
| 2022 | $-50.49M | -11.1% |
| 2021 | $-45.44M | -3.3% |
| 2020 | $-43.99M | -22.3% |
| 2019 | $-35.96M | +5.2% |
| 2018 | $-37.94M | -66.3% |
| 2017 | $-22.81M | -206.0% |
| 2016 | $-7.46M | -295.8% |
| 2015 | $-1.88M | - |